Interpharma won’t challenge Precedex patent validity ruling

Healthcare 2019-10-03 8:54 pm By Cat Fredenburgh | Melbourne

Please login to bookmark

Australian drug maker InterPharma will not appeal a ruling that dismissed its challenge to the validity of global pharmaceutical giant Pfizer’s patent for sedative drug Precedex.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au